NHL
Clinical trials for NHL explained in plain language.
Never miss a new study
Get alerted when new NHL trials appear
Sign up with your email to follow new studies for NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can pressurized oxygen boost cord blood transplants?
Disease control OngoingThis study tests whether giving patients hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) after an umbilical cord blood stem cell transplant helps the donated stem cells grow faster. The trial enrolls people with blood cancers like leukemia or lymphoma who lack …
Matched conditions: NHL
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Engineered immune cells get a boost: new combo therapy targets Hard-to-Treat blood cancers
Disease control OngoingThis early-phase trial tests a new approach to treating certain blood cancers (like lymphoma and leukemia) that have come back or not responded to standard treatment. The therapy uses a patient's own immune cells, engineered to recognize and attack cancer cells (SYNCAR-001), alon…
Matched conditions: NHL
Phase: PHASE1 • Sponsor: Synthekine • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug cocktail aims to shrink lymphoma without chemo
Disease control OngoingThis phase 2 trial tests whether combining copanlisib and rituximab can slow or stop follicular lymphoma in people who haven't had treatment yet. About 33 participants will receive the drugs through an IV over several cycles. The main goal is to see how many achieve a complete re…
Matched conditions: NHL
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Immunotherapy after chemo may keep aggressive lymphoma at bay
Disease control OngoingThis phase 2 study tests whether the immunotherapy drug atezolizumab can help prevent relapse in people with high-risk diffuse large B-cell lymphoma (DLBCL) who have already achieved remission with standard chemotherapy (R-CHOP). About 109 adults aged 18–75 are receiving 18 cycle…
Matched conditions: NHL
Phase: PHASE2 • Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC